M S Ewer
Overview
Explore the profile of M S Ewer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
828
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Swain S, Whaley F, Gerber M, Ewer M, BIANCHINE J, Gams R
J Clin Oncol
. 1997 Apr;
15(4):1333-40.
PMID: 9193324
Purpose: To assess whether dexrazoxane (DZR) given after a cumulative doxorubicin dose of 300 mg/m2 confers cardioprotection in patients with advanced breast cancer treated with fluorouracil, doxorubicin, and cyclophosphamide (FAC)....
12.
Swain S, Whaley F, Gerber M, Weisberg S, York M, Spicer D, et al.
J Clin Oncol
. 1997 Apr;
15(4):1318-32.
PMID: 9193323
Purpose: To determine the cardioprotective effect of dexrazoxane (DZR) used in a doxorubicin-based combination therapy in advanced breast cancer. Patients And Methods: Between November 1988 and January 1991, 534 patients...
13.
Anderlini P, Benjamin R, Wong F, Kantarjian H, Andreeff M, Kornblau S, et al.
J Clin Oncol
. 1995 Nov;
13(11):2827-34.
PMID: 7595745
Purpose: To estimate the incidence of idarubicin (IDA)-related cardiomyopathy in acute myeloid leukemia (AML) and myelodysplasia (MDS). Patients And Methods: We analyzed a group of 127 AML/MDS patients who received...
14.
Ewer M, Taubert J
Cancer
. 1995 Oct;
76(7):1268-74.
PMID: 8630908
Background: Advance directives are associated with considerable controversy. The goal of this study was to evaluate the outcomes of critically ill patients with cancer who were admitted to the intensive...
15.
Massin E, Zeluff B, Carrol C, Radovancevic B, Benjamin R, Ewer M, et al.
Circulation
. 1994 Sep;
90(3):1552-6.
PMID: 8087962
No abstract available.
16.
Ali M, Ewer M, Gibbs H, Swafford J, Graff K
Cancer
. 1994 Jul;
74(1):182-8.
PMID: 8004574
Background: The most frequently encountered doxorubicin related cardiac toxicity is a dose-related myocardial dysfunction occurring 1-6 months after chemotherapy. Recently, late cardiotoxicity has been the focus of interest. This paper...
17.
Mackay B, Ewer M, Carrasco C, Benjamin R
Ultrastruct Pathol
. 1994 Jan;
18(1-2):203-11.
PMID: 8191628
Ultrastructural evaluation of endomyocardial biopsy specimens is a sensitive and effective method with which to detect and quantitate cardiotoxicity produced by anthracylines. The procedure and grading system used at the...
18.
Ewer M, Ali M, Gibbs H, Swafford J, Graff K, Cangir A, et al.
Acta Oncol
. 1994 Jan;
33(6):645-9.
PMID: 7946442
The purpose of the study was to compare systolic and diastolic function in pediatric patients treated with doxorubicin. Left ventricular function was evaluated in 61 children prior to and following...
19.
Gibbs H, Swafford J, Ewer M, Ali M
Oncology (Williston Park)
. 1992 Oct;
6(10):25-9; discussion 29-32.
PMID: 1390012
Cardiac emergencies may be encountered during the management of patients with cancer, both in those with underlying cardiovascular disease and those with no previous history of cardiac problems. Both surgical...
20.
Ewer M, Ali M, Gibbs H, Swafford J
Am J Crit Care
. 1992 Sep;
1(2):108-10.
PMID: 1339173
Flow-directed pulmonary artery catheters provide important information regarding intravascular volume status, cardiac function and vascular resistance. We describe an unusual complication of pulmonary artery catheterization in which a knot formed...